Inicio > BIGG > Resultado de la búsqueda

    Resultados: 2

    Časná diagnostika a léčba chronické virové hepatitidy C (VHC)

    Czech Republic. Ministry of Health.
    According to WHO data, 71 million people worldwide were infected with hepatitis C virus (HCV) in 2015, corresponding to a prevalence of 1%. 399,000 people die annually from complications of liver cirrhosis, including hepatocellular carcinoma. This KDP answers the following clinical questions: Diagnos...
    Hepatitis C/tratamiento farmacológico, Hepacivirus/inmunología, Hepatitis C/epidemiología, Transmisión Vertical de Enfermedad Infecciosa, República Checa/epidemiología, Antivirales/uso terapéutico, Hepacivirus/genética, Genotipo
    Texto completo

    The use of molecular line probe assays for the detection of resistance to second-line anti-tuberculosis drugs: policy guidance

    World Health Organization.
    This document provides a summary of the evidence and recommendations for the use of SL-LPA for the detection of mutations associated with resistance to fluoroquinolones and SLID in patients with RR-TB and/or MDR-TB. The objectives of this policy guidance are to assess and compare the diagnostic accuracy ...
    Tuberculosis Resistente a Múltiples Medicamentos/diagnóstico, Antibióticos Antituberculosos/farmacología, Técnicas de Sonda Molecular, Pruebas de Sensibilidad Microbiana, Fluoroquinolonas/uso terapéutico, Farmacorresistencia Bacteriana/genética, Genotipo, Mutación, Tuberculosis Resistente a Múltiples Medicamentos/genética, Mycobacterium tuberculosis/efectos de los fármacos, Mycobacterium tuberculosis/genética
    Texto completo